loader
Please Wait
Applying Filters...

Euroapi Company Header Euroapi Company Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Ladarixin, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Ladarixin

    DEVELOPMENTS

    PharmaCompass

    Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.

    One Pharma aims to be one of the leading generic companies in Europe.

    2D Structure
    1. Also known as: 849776-05-2, Ladarixin [inn], (r)-4-[1-(methylsulfonamido)-1-oxo-2-propyl]phenyl trifluoromethanesulfonate, 4-((2r)-1-oxo-1-(methanesulfonamido)propan-2-yl)phenyl trifluoromethanesulfonate, Deh7q6472o, 849776-05-2 (free)
    Molecular Formula
    C11H12F3NO6S2
    Molecular Weight
    375.3  g/mol
    InChI Key
    DDLPYOCJHQSVSZ-SSDOTTSWSA-N
    FDA UNII
    DEH7Q6472O
    Ladarixin is under investigation in clinical trial NCT04628481 (A Study of Oral Ladarixin in New-onset Type 1 Diabetes and a Low Residual -Cell Function).
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    [4-[(2R)-1-(methanesulfonamido)-1-oxopropan-2-yl]phenyl] trifluoromethanesulfonate
    2.1.2 InChI
    InChI=1S/C11H12F3NO6S2/c1-7(10(16)15-22(2,17)18)8-3-5-9(6-4-8)21-23(19,20)11(12,13)14/h3-7H,1-2H3,(H,15,16)/t7-/m1/s1
    2.1.3 InChI Key
    DDLPYOCJHQSVSZ-SSDOTTSWSA-N
    2.1.4 Canonical SMILES
    CC(C1=CC=C(C=C1)OS(=O)(=O)C(F)(F)F)C(=O)NS(=O)(=O)C
    2.1.5 Isomeric SMILES
    C[C@H](C1=CC=C(C=C1)OS(=O)(=O)C(F)(F)F)C(=O)NS(=O)(=O)C
    2.2 Other Identifiers
    2.2.1 UNII
    DEH7Q6472O
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 2'-((4'-trifluoromethanesulfonyloxy)phenyl)-n-methanesulfonylpropionamide

    2. Df 2156a

    3. Df 2156y

    4. Df-2156a

    5. Df-2156y

    6. Df2156a

    7. Df2156y

    2.3.2 Depositor-Supplied Synonyms

    1. 849776-05-2

    2. Ladarixin [inn]

    3. (r)-4-[1-(methylsulfonamido)-1-oxo-2-propyl]phenyl Trifluoromethanesulfonate

    4. 4-((2r)-1-oxo-1-(methanesulfonamido)propan-2-yl)phenyl Trifluoromethanesulfonate

    5. Deh7q6472o

    6. 849776-05-2 (free)

    7. Methanesulfonic Acid, 1,1,1-trifluoro-, 4-((1r)-1-methyl-2-((methylsulfonyl)amino)-2-oxoethyl)phenyl Ester

    8. Methanesulfonic Acid, Trifluoro-, 4-((1r)-1-methyl-2-((methylsulfonyl)amino)-2-oxoethyl)phenyl Ester

    9. Df2156a

    10. Unii-deh7q6472o

    11. Ladarixin [who-dd]

    12. Schembl251618

    13. Chembl189475

    14. Dtxsid50234030

    15. Df-2156a

    16. Ac6925

    17. Bdbm50475370

    18. Akos037649625

    19. Cs-12792

    20. Hy-19519

    21. Cs-0015618

    22. A857904

    23. Q27276351

    24. (r)-(-)-n-(2-(4-(trifluoromethanesulfonyloxy)phenyl)propionyl)methanesulfonamide

    25. [4-[(2r)-1-(methanesulfonamido)-1-oxopropan-2-yl]phenyl] Trifluoromethanesulfonate

    2.4 Create Date
    2006-10-26
    3 Chemical and Physical Properties
    Molecular Weight 375.3 g/mol
    Molecular Formula C11H12F3NO6S2
    XLogP32
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count9
    Rotatable Bond Count5
    Exact Mass375.00581394 g/mol
    Monoisotopic Mass375.00581394 g/mol
    Topological Polar Surface Area123 Ų
    Heavy Atom Count23
    Formal Charge0
    Complexity624
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Treatment of type I diabetes mellitus

    Post Enquiry
    POST ENQUIRY